Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

by K O'Rourke, K Morris, G A Kennedy
Cancer ()
Get full text at journal

Cite this document (BETA)

Readership Statistics

1 Reader on Mendeley
by Discipline
 
100% Medicine and Dentistry
by Academic Status
 
100% Researcher
by Country
 
100% United Kingdom

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in